Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioharvest Sciences (BHST) EBIT (2023 - 2025)

Historic EBIT for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to -$920000.0.

  • Bioharvest Sciences' EBIT rose 5623.22% to -$920000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year increase of 7292.92%. This contributed to the annual value of -$7.0 million for FY2024, which is 2987.16% up from last year.
  • Latest data reveals that Bioharvest Sciences reported EBIT of -$920000.0 as of Q3 2025, which was up 5623.22% from -$1.8 million recorded in Q2 2025.
  • Bioharvest Sciences' EBIT's 5-year high stood at $2.9 million during Q2 2023, with a 5-year trough of -$17.4 million in Q4 2023.
  • For the 3-year period, Bioharvest Sciences' EBIT averaged around -$2.4 million, with its median value being -$1.7 million (2024).
  • Data for Bioharvest Sciences' EBIT shows a peak YoY increase of 9029.51% (in 2024) and a maximum YoY decrease of 20473.34% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Bioharvest Sciences' EBIT stood at -$17.4 million in 2023, then surged by 90.3% to -$1.7 million in 2024, then soared by 45.47% to -$920000.0 in 2025.
  • Its last three reported values are -$920000.0 in Q3 2025, -$1.8 million for Q2 2025, and -$1.7 million during Q1 2025.